[go: up one dir, main page]

CN117598926A - A skin barrier repair composition containing recombinant collagen and its application - Google Patents

A skin barrier repair composition containing recombinant collagen and its application Download PDF

Info

Publication number
CN117598926A
CN117598926A CN202311625054.2A CN202311625054A CN117598926A CN 117598926 A CN117598926 A CN 117598926A CN 202311625054 A CN202311625054 A CN 202311625054A CN 117598926 A CN117598926 A CN 117598926A
Authority
CN
China
Prior art keywords
skin barrier
barrier repair
recombinant collagen
skin
repair composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202311625054.2A
Other languages
Chinese (zh)
Inventor
肖湲
孙怀庆
王宁
裴运林
聂艳峰
郭朝万
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Marubi Biological Technology Co Ltd
Original Assignee
Guangdong Marubi Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Marubi Biological Technology Co Ltd filed Critical Guangdong Marubi Biological Technology Co Ltd
Priority to CN202311625054.2A priority Critical patent/CN117598926A/en
Publication of CN117598926A publication Critical patent/CN117598926A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

本发明涉及一种含有重组胶原蛋白的肌肤屏障修复组合物及其应用,所述肌肤屏障修复组合物包括重组胶原蛋白、芋螺肽、裂褶菌多糖和依克多因。本发明创造性地将重组胶原蛋白、芋螺肽、裂褶菌多糖和依克多因四种组分进行联用,四者从不同维度全方位地改善皮肤的屏障受损问题同时强化肌肤屏障,四种组分相辅相成,存在潜在的相互促进效果,在上述功效上具有协同增效作用,能够高效改善由肌肤屏障受损引起的皮肤综合问题。The invention relates to a skin barrier repair composition containing recombinant collagen and its application. The skin barrier repair composition includes recombinant collagen, conotide, schizophyllan and ectoin. The invention creatively combines four components: recombinant collagen, conotide, schizophyllan and ectoin. The four components comprehensively improve the problem of skin barrier damage from different dimensions while strengthening the skin barrier. The four components complement each other and have potential mutual promotion effects. They have a synergistic effect on the above-mentioned effects and can effectively improve comprehensive skin problems caused by damaged skin barriers.

Description

一种含有重组胶原蛋白的肌肤屏障修复组合物及其应用A skin barrier repair composition containing recombinant collagen and its application

技术领域Technical field

本发明属于化妆品技术领域,涉及一种含有重组胶原蛋白的肌肤屏障修复组合物及其应用。The invention belongs to the technical field of cosmetics and relates to a skin barrier repair composition containing recombinant collagen and its application.

背景技术Background technique

健康的皮肤可以有效地挽留住水分,从而保持皮肤良好的弹性和光泽的外表。但皮肤受生活环境和自身生理条件的影响,肌肤可能出现敏感、干燥脱皮、油脂分泌过剩、产生色斑、皮肤松弛老化、红血丝等肌肤问题,究其最主要的原因就是肌肤屏障受到损害。肌肤屏障是由角质层和皮脂膜共同构建的一层保护性结构,其既可以缓冲理化刺激、有效抑制细菌滋生、阻隔细菌、病毒、真菌对肌肤的伤害,又可以锁住水分,防止水分蒸发,从而实现保持水分的功能。肌肤屏障受到损害,导致肌肤遭受细菌、病毒、真菌的侵蚀,也会导致肌肤内的水分肆无忌惮的的蒸发,进而使肌肤出现各种问题,例如易敏感、皮肤干燥、皮肤松弛老化等等。Healthy skin can effectively retain moisture, thereby maintaining good skin elasticity and shiny appearance. However, the skin is affected by the living environment and its own physiological conditions. The skin may suffer from sensitivity, dryness and peeling, excessive oil secretion, spots, sagging and aging skin, redness and other skin problems. The main reason is that the skin barrier is damaged. The skin barrier is a protective structure composed of the stratum corneum and the sebum film. It can buffer physical and chemical stimulation, effectively inhibit bacterial growth, block the damage to the skin caused by bacteria, viruses, and fungi, and can lock in moisture and prevent moisture from evaporating. , thereby achieving the function of retaining moisture. The skin barrier is damaged, causing the skin to be eroded by bacteria, viruses, and fungi. It will also cause the water in the skin to evaporate unbridled, causing various skin problems, such as sensitivity, dry skin, sagging and aging skin, etc.

目前常用的修复肌肤屏障的手段就是充分补水,但传统化妆品中的水分大部分仅存在于皮肤表层,皮肤表层水分的蒸发速度要远大于吸收速度,能够被肌肤吸收的水分量有限,导致肌肤屏障修复的速度较慢,耗时较长,而且简单的补水对皮肤敏感问题和皮肤松弛老化并无有效的改善作用。The commonly used method to repair the skin barrier is to fully hydrate. However, most of the water in traditional cosmetics only exists on the surface of the skin. The evaporation rate of water on the surface of the skin is much faster than the absorption rate. The amount of water that can be absorbed by the skin is limited, resulting in skin barrier The repair speed is slow and takes a long time, and simple hydration has no effective improvement effect on skin sensitivity problems and skin sagging and aging.

CN116172934A公开了一种兼具皮肤屏障修复功能和补水功能的组合物及其应用,包括下述质量份组分:香附子根提取物0.1-20份,齿叶乳香提取物0.3-20份,没药叶细胞提取物0.2-20份,甘油1-30份,去离子水10-90份。该组合物对缓解肌肤干燥、恢复肌肤表皮屏障、提高皮肤含水量具有明显的效果。但该组合物对肌肤屏障修复的速度较慢,耗时较长,而且对由肌肤屏障受损引起的皮肤综合问题无法高效地改善。CN116172934A discloses a composition with both skin barrier repair function and hydration function and its application, including the following components by mass: 0.1-20 parts of Cyperus rotundus root extract, 0.3-20 parts of Boswellia serrata extract, no. 0.2-20 parts of medicinal leaf cell extract, 1-30 parts of glycerin, 10-90 parts of deionized water. The composition has obvious effects on relieving dry skin, restoring skin epidermal barrier, and increasing skin moisture content. However, this composition repairs the skin barrier slowly and takes a long time, and it cannot effectively improve the comprehensive skin problems caused by the damaged skin barrier.

CN109394595A公开了一种具有深层补水和屏障修复的面膜精华液,配方重量配比为二裂酵母发酵产物滤液:10-97%,纯化水:0-90%,尿囊素:0.1-0.2%,多元醇:1-8%,聚甘油保湿剂:0.5-2%,EDTA二钠:0.02-0.1%,馨鲜酮:0.3-0.6%,1,2-己二醇:0.3-0.6%,卡波姆:0.1-0.2%,精氨酸:0.1-0.2%,透明质酸钠:0.01-0.1%,羟乙基纤维素:0.01-0.1%,羟基化卵磷脂:0.1-0.2%;具有深层补水的功效,具有屏障修复的作用。但该产品对肌肤屏障修复的速度较慢,耗时较长,而且对由肌肤屏障受损引起的皮肤综合问题无法高效地改善。CN109394595A discloses a facial mask essence with deep hydration and barrier repair. The weight ratio of the formula is bifid yeast fermentation product filtrate: 10-97%, purified water: 0-90%, and allantoin: 0.1-0.2%. Polyol: 1-8%, polyglycerol humectant: 0.5-2%, disodium EDTA: 0.02-0.1%, cinnamonone: 0.3-0.6%, 1,2-hexanediol: 0.3-0.6%, card Bohm: 0.1-0.2%, Arginine: 0.1-0.2%, Sodium Hyaluronate: 0.01-0.1%, Hydroxyethylcellulose: 0.01-0.1%, Hydroxylated Lecithin: 0.1-0.2%; with deep It has the effect of hydrating and repairing the barrier. However, this product repairs the skin barrier slowly and takes a long time, and it cannot effectively improve the comprehensive skin problems caused by damaged skin barrier.

因此,开发一种能够高效改善由肌肤屏障受损引起的皮肤综合问题的产品是非常有必要的。Therefore, it is very necessary to develop a product that can effectively improve the comprehensive skin problems caused by damaged skin barrier.

发明内容Contents of the invention

针对现有技术的不足,本发明的目的在于提供一种含有重组胶原蛋白的肌肤屏障修复组合物及其应用。In view of the shortcomings of the existing technology, the object of the present invention is to provide a skin barrier repair composition containing recombinant collagen and its application.

为达到此发明目的,本发明采用以下技术方案:In order to achieve the purpose of this invention, the present invention adopts the following technical solutions:

第一方面,本发明提供一种含有重组胶原蛋白的肌肤屏障修复组合物,所述肌肤屏障修复组合物包括重组胶原蛋白、芋螺肽、裂褶菌多糖和依克多因。In a first aspect, the present invention provides a skin barrier repair composition containing recombinant collagen. The skin barrier repair composition includes recombinant collagen, conotide, schizophyllan and ectoin.

芋螺肽具有加快局部血液循环和局部新陈代谢的作用,能够刺激皮肤的活跃性,使皮肤细胞的活跃性增强,可以延缓皮肤衰老,且其成分的营养丰富,获得优异的保养皮肤的效果。裂褶菌多糖能够激活皮肤免疫细胞以及其他组织细胞的活性,提高整个皮肤组织的抵抗力和修复能力,同时也具有良好的皮肤保湿功能。依克多因在抗衰老、防紫外线、抗氧化、保湿及抑制炎症等方面都颇具潜力,其能提升皮肤细胞的免疫防护能力,具有较好的抗过敏、抗炎效果;增加细胞修复能力,使皮肤能有效对抗微生物及过敏原的入侵,对皮肤有很好的保护及修复功效,加速皮肤健康的恢复。在对抗紫外线方面,依克多因能修复紫外线导致的细胞DNA损伤,能有效减少晒伤细胞的生成,防止细胞膜结构受到伤害。胶原蛋白能够为皮肤及时补充胶原蛋白,强化肌肤屏障,抵抗环境伤害,将保持皮肤保持在健康的状态。Conotide can accelerate local blood circulation and local metabolism, stimulate skin activity, enhance the activity of skin cells, and delay skin aging. Its ingredients are rich in nutrients and have excellent skin care effects. Schizophyllum can activate the activity of skin immune cells and other tissue cells, improve the resistance and repair ability of the entire skin tissue, and also has good skin moisturizing function. Ectoin has great potential in anti-aging, anti-ultraviolet, anti-oxidation, moisturizing and inhibiting inflammation. It can improve the immune protection ability of skin cells and has good anti-allergic and anti-inflammatory effects; it increases cell repair ability, It enables the skin to effectively resist the invasion of microorganisms and allergens, has good protection and repair effects on the skin, and accelerates the recovery of skin health. In terms of fighting against ultraviolet rays, Ectoin can repair cell DNA damage caused by ultraviolet rays, effectively reduce the generation of sunburned cells, and prevent damage to cell membrane structures. Collagen can replenish collagen to the skin in a timely manner, strengthen the skin barrier, resist environmental damage, and keep the skin in a healthy state.

本发明创造性地将重组胶原蛋白、芋螺肽、裂褶菌多糖和依克多因四种组分进行联用,四者从不同维度全方位地改善皮肤的屏障受损问题同时强化肌肤屏障,四种组分相辅相成,存在潜在的相互促进效果,在上述功效上具有协同增效作用,能够高效改善由肌肤屏障受损引起的皮肤综合问题。The invention creatively combines four components: recombinant collagen, conotide, schizophyllan and ectoin. The four components comprehensively improve the problem of skin barrier damage from different dimensions while strengthening the skin barrier. The four components complement each other and have potential mutual promotion effects. They have a synergistic effect on the above-mentioned effects and can effectively improve comprehensive skin problems caused by damaged skin barriers.

优选地,所述肌肤屏障修复组合物以质量份数计包括重组胶原蛋白0.01-2份、芋螺肽0.1-3份、裂褶菌多糖0.1-0.5份和依克多因0.1-1份。Preferably, the skin barrier repair composition includes 0.01-2 parts of recombinant collagen, 0.1-3 parts of conotide, 0.1-0.5 parts of Schizophyllan and 0.1-1 part of ectoin in terms of parts by mass.

基于上述各成分之间的潜在相互作用,当上述四种成分以特定的质量配比关系进行组合时,其在强化肌肤屏障和改善由肌肤屏障受损引起的皮肤综合问题上具有更好的效果。Based on the potential interactions between the above ingredients, when the above four ingredients are combined in a specific mass ratio, they have better effects in strengthening the skin barrier and improving comprehensive skin problems caused by damaged skin barrier. .

所述重组胶原蛋白的质量份数可以选择为0.01份、0.03份、0.05份、0.08份、0.1份、0.2份、0.4份、0.5份、0.8份、1份、1.2份、1.4份、1.5份、1.8份、2份等;所述芋螺肽的质量份数可以选择为0.1份、0.3份、0.5份、0.8份、1份、1.2份、1.4份、1.5份、1.8份、2份、2.2份、2.4份、2.5份、2.8份、3份等;所述裂褶菌多糖的质量份数可以选择为0.1份、0.15份、0.2份、0.25份、0.3份、0.35份、0.4份、0.45份、0.5份等;所述依克多因的质量份数可以选择为0.1份、0.2份、0.3份、0.4份、0.5份、0.6份、0.7份、0.8份、0.9份、1份等。上述各项数值范围内的其他具体点值均可选择,在此便不再一一赘述。The mass parts of the recombinant collagen can be selected from 0.01 part, 0.03 part, 0.05 part, 0.08 part, 0.1 part, 0.2 part, 0.4 part, 0.5 part, 0.8 part, 1 part, 1.2 part, 1.4 part, 1.5 part , 1.8 parts, 2 parts, etc.; the mass parts of the conopeptide can be selected from 0.1 parts, 0.3 parts, 0.5 parts, 0.8 parts, 1 part, 1.2 parts, 1.4 parts, 1.5 parts, 1.8 parts, 2 parts, 2.2 parts, 2.4 parts, 2.5 parts, 2.8 parts, 3 parts, etc.; the mass parts of the Schizophyllan polysaccharide can be selected from 0.1 parts, 0.15 parts, 0.2 parts, 0.25 parts, 0.3 parts, 0.35 parts, 0.4 parts, 0.45 parts, 0.5 parts, etc.; the mass parts of ectoine can be selected from 0.1 parts, 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts, 0.6 parts, 0.7 parts, 0.8 parts, 0.9 parts, 1 part, etc. . Other specific point values within the above-mentioned numerical ranges can be selected, so I will not go into details here.

优选地,编码所述重组胶原蛋白的核苷酸序列为SEQ ID NO:1所示的序列。Preferably, the nucleotide sequence encoding the recombinant collagen is the sequence shown in SEQ ID NO: 1.

相较于其他来源的胶原蛋白或重组胶原蛋白,本发明还发现上述特定来源的重组胶原蛋白在强化肌肤屏障和改善由肌肤屏障受损引起的皮肤综合问题方面的效果更优。Compared with collagen or recombinant collagen from other sources, the present invention also found that the recombinant collagen from the above specific source is more effective in strengthening the skin barrier and improving comprehensive skin problems caused by damaged skin barrier.

SEQ ID NO:1:SEQ ID NO:1:

GGGCCTCAAGGTATTGCTGGACAGCGTGGTGTGGTCGGCCTGCCTGGTCAGAGAGGAGAGAGAGGCTTCCCTGGTCTTCCTGGCCCCTCTGGTGAACCTGGCAAACAAGGTCCCTCTGGAGCAAGTGGTGAACGTGGTCCCCCTGGTCCCATGGGCCCCCCTGGATTGGCTGGACCCCCTGGTGAATCTGGACGTGAGGGGGCTCCTGGTGCCGAAGGTTCCCCTGGACGAGACGGTTCTCCTGGCGCCAAGGGTGACCGTGGTGAGACCGGCCCCGCTGGACCCCCTGGTGCTCCTGGTGCTCCTGGTGCCCCTGGCCCCGTTGGCCCTGCTGGCAAGAGTGGTGATCGTGGTGAGACTGGTCCTGCTGGTCCCGCCGGAGAACGAGGTGGCCCTGGAGGACCTGGCCCTCAGGGTCCTCCTGGAAAGAATGGTGAAACTGGACCTCAGGGACCCCCAGGGCCTACTGGGCCTGGTGGTGACAAAGGAGACACAGGACCCCCTGGTCCACAAGGATTACAAGGCTTGCCTGGTACAGGTGGTCCTCCAGGAGAAAATGGAAAACCTGGGGAACCAGGTCCAAAGGGTGATGCCGGTGCACCTGGAGCTCCAGGAGGCAAGGGTGATGCTGGTGCCCCTGGTGAACGTGGACCTCCTGGATTGGCAGGGGCCCCAGGACTTAGAGGTGGAGCTGGTCCCCCTGGTCCCGAAGGAGGAAAGGGTGCTGCTGGTCCTCCTGGGCCACCTGGTGCTGCTGGTACTCCTGGTCTGCAAGGAATGCCTGGACCTGGTCCTTGCTGTGGTGGTTAA。GGGCCTCAAGGTATTGCTGGACAGCGTGGTGTGGTCGGCCTGCCTGGTCAGAGAGGAGAGAGGCTTCCCTGGTCTTCCTGGCCCCTCTGGTGAACCTGGCAAACAAGGTCCCTCTGGAGCAAGTGGTGAACGTGGTCCCTCTGGTCCCATGGGCCCCTGGATTGGCTGGACCCCCTGGTGAATCTGGACGTGAGGGGGCTCCTGGTGCCGAAGGTTCCCCTGGACGAGACGGTTCTCCTGGCGCCAAGGGTG ACCGTGGTGAGACCGGCCCCGCTGGACCCCCTGGTGCTCCTGGTGCTCCTGGTGCCCCTGGCCCCGTTGGCCCTGCTGGCAAGAGTGGTTGATCGTGGTGAGACTGGTCCTGCTGGTCCCGCCGGAGAACGAGGTGGCCCTGGAGGACCTGGCCCTCAGGGTCCTCCTGGAAAGAATGGTGAAACTGGACCTCAGGGACCCCCAGGGCCTACTGGGCCTGGTGGTGACAAAGGAGACACAGGACCCTGGTCCACAAGGATTACAAGGC TTGCCTGGTACAGGTGGTCCTCCAGGAGAAAATGGAAAACCTGGGGAACCAGGTCCAAAGGGTGATGCCGGTGCACCTGGAGCTCCAGGAGGCAAGGGTGATGCTGGTGCCCCTGGTGAACGTGGACCTCCTGGATTGGCAGGGGCCCCAGGACTTAGAGGTGGAGCTGGTCCCCCTGGTCCCGAAGGAGGAAAGGGTGCTGCTGGTCCTCCTGGGCCACCTGGTGCTGCTGGTACTCCTGGTCTGCAAGGAATGCCTGGACC TGGTCCTTGCTGTGGTGGTTAA.

第二方面,本发明提供根据第一方面所述的含有重组胶原蛋白的肌肤屏障修复组合物在制备化妆品中的应用。In a second aspect, the present invention provides the use of the skin barrier repair composition containing recombinant collagen according to the first aspect in the preparation of cosmetics.

优选地,所述含有重组胶原蛋白的肌肤屏障修复组合物在所述化妆品中的质量百分含量为0.1-15%,例如0.1%、0.5%、1%、2%、3%、4%、5%、6%、7%、10%、11%、12%、13%、15%等。该数值范围内的其他具体点值均可选择,在此便不再一一赘述。Preferably, the mass percentage of the skin barrier repair composition containing recombinant collagen in the cosmetic is 0.1-15%, such as 0.1%, 0.5%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 10%, 11%, 12%, 13%, 15%, etc. Other specific point values within this numerical range can be selected and will not be described one by one here.

第三方面,本发明提供一种强化肌肤屏障修复的乳液,所述乳液的制备原料以质量百分含量计包括:第一方面所述的含有重组胶原蛋白的肌肤屏障修复组合物0.1-15%、油相1-20%、乳化剂1-10%和水50-90%。In a third aspect, the present invention provides an emulsion that strengthens skin barrier repair. The raw materials for preparing the emulsion include, in terms of mass percentage: 0.1-15% of the skin barrier repair composition containing recombinant collagen described in the first aspect. , oil phase 1-20%, emulsifier 1-10% and water 50-90%.

所述肌肤屏障修复组合物的质量百分含量可以选择为0.1%、0.5%、1%、2%、3%、4%、5%、6%、7%、10%、11%、12%、13%、15%等;所述油相的质量百分含量可以选择为1%、2%、3%、4%、5%、6%、7%、8%、9%、10%、12%、14%、15%、18%、20%等;所述乳化剂的质量百分含量可以选择为1%、2%、3%、4%、5%、6%、7%、8%、9%、10%等;所述水的质量百分含量可以选择为50%、55%、60%、65%、70%、75%、80%、85%、90%等。上述各项数值范围内的其他具体点值均可选择,在此便不再一一赘述。The mass percentage of the skin barrier repair composition can be selected from 0.1%, 0.5%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 10%, 11%, 12% , 13%, 15%, etc.; the mass percentage of the oil phase can be selected from 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 12%, 14%, 15%, 18%, 20%, etc.; the mass percentage of the emulsifier can be selected from 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8 %, 9%, 10%, etc.; the mass percentage of water can be selected from 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, etc. Other specific point values within the above-mentioned numerical ranges can be selected, so I will not go into details here.

优选地,所述油相包括甘油辛酸酯、角鲨烷、油橄榄果油、白池花籽油、霍霍巴油、牛油果树果脂、甜扁桃油、葡萄籽油、辛酸/癸酸甘油三酯、氢化椰油甘油酯、植物甾醇异硬脂酸酯、异壬酸异壬酯、花生醇、维生素A、维生素E或维生素F中的任意一种或至少两种的组合。优选白池花籽油、甜扁桃油、葡萄籽油和维生素E的组合。Preferably, the oil phase includes glyceryl caprylate, squalane, oleocanthal oil, albacore oil, jojoba oil, avocado butter, sweet almond oil, grape seed oil, caprylic/capric triglyceride , any one or a combination of at least two of hydrogenated coconut glyceryl, phytosterol isostearate, isononyl isononate, arachidyl alcohol, vitamin A, vitamin E or vitamin F. A combination of white pond flower seed oil, sweet almond oil, grape seed oil and vitamin E is preferred.

优选地,所述乳化剂包括甘油硬脂酸酯、鲸蜡硬脂醇、硬脂酰乳酰乳酸钠、甘油硬脂酸酯柠檬酸酯、胆甾醇、鲸蜡硬脂醇橄榄油酸酯、山梨坦橄榄油酸酯、山梨坦硬脂酸酯、聚甘油-10油酸酯或聚山梨醇酯-60中的任意一种或至少两种的组合。Preferably, the emulsifier includes glycerol stearate, cetearyl alcohol, sodium stearoyl lactylate, glyceryl stearate citrate, cholesterol, cetearyl olive oil, sorbate Any one or a combination of at least two of polyglyceryl oleate, sorbitan stearate, polyglycerol-10 oleate or polysorbate-60.

优选地,所述乳液的制备原料以质量百分含量计还包括:植物源调理剂1-15%、pH调节剂0.1-2%、螯合剂0.01-0.5%、抗氧化剂0.05-0.5%、芳香剂0.1-0.5%中的任意一种或至少两种的组合。Preferably, the raw materials for preparing the emulsion also include, in terms of mass percentage: 1-15% plant-derived conditioner, 0.1-2% pH regulator, 0.01-0.5% chelating agent, 0.05-0.5% antioxidant, aromatic Any one or a combination of at least two agents 0.1-0.5%.

所述植物源调理剂的质量百分含量可以选择为1%、2%、3%、4%、5%、6%、7%、10%、11%、12%、13%、15%等;所述pH调节剂的质量百分含量可以选择为0.1%、0.3%、0.5%、0.8%、1%、1.2%、1.4%、1.6%、1.8%、2%等;所述螯合剂的质量百分含量可以选择为0.01%、0.03%、0.05%、0.08%、0.1%、0.15%、0.2%、0.3%、0.4%、0.5%等;所述抗氧化剂的质量百分含量可以选择为0.05%、0.08%、0.1%、0.15%、0.2%、0.3%、0.4%、0.5%等;所述芳香剂的质量百分含量可以选择为0.1%、0.15%、0.2%、0.3%、0.4%、0.5%等;上述各项数值范围内的其他具体点值均可选择,在此便不再一一赘述。The mass percentage of the plant-derived conditioner can be selected from 1%, 2%, 3%, 4%, 5%, 6%, 7%, 10%, 11%, 12%, 13%, 15%, etc. ; The mass percentage of the pH regulator can be selected from 0.1%, 0.3%, 0.5%, 0.8%, 1%, 1.2%, 1.4%, 1.6%, 1.8%, 2%, etc.; The chelating agent The mass percentage content can be selected as 0.01%, 0.03%, 0.05%, 0.08%, 0.1%, 0.15%, 0.2%, 0.3%, 0.4%, 0.5%, etc.; the mass percentage content of the antioxidant can be selected as 0.05%, 0.08%, 0.1%, 0.15%, 0.2%, 0.3%, 0.4%, 0.5%, etc.; the mass percentage of the fragrance can be selected from 0.1%, 0.15%, 0.2%, 0.3%, 0.4 %, 0.5%, etc.; other specific point values within the above numerical range can be selected, so I will not go into details here.

优选地,所述植物源调理剂包括金缕梅提取物和/或灯盏花提取物。Preferably, the plant-derived conditioning agent includes witch hazel extract and/or breviscapus extract.

本发明还创造性地发现在上述产品中进一步加入金缕梅提取物和/或灯盏花提取物尤其是金缕梅提取物和灯盏花提取物的组合时,能够进一步提高产品的屏障修复方面的效果。其中金缕梅提取物和灯盏花提取物在发挥上述功效上也存在协同促进作用。The present invention also creatively found that when witch hazel extract and/or breviscapus extract are further added to the above products, especially the combination of witch hazel extract and breviscapus extract, the barrier repair effect of the product can be further improved. . Witch hazel extract and Erigeron flower extract also have a synergistic effect in exerting the above effects.

第四方面,本发明提供根据第三方面所述的强化肌肤屏障修复的乳液的制备方法,所述制备方法包括如下步骤:In a fourth aspect, the present invention provides a method for preparing an emulsion that strengthens skin barrier repair according to the third aspect, and the preparation method includes the following steps:

(1)将水与肌肤屏障修复组合物在25-40℃下混合均质,得到水相;将油相与乳化剂在35-50℃下混合均质,得到油相;(1) Mix and homogenize water and the skin barrier repair composition at 25-40°C to obtain a water phase; mix and homogenize the oil phase and emulsifier at 35-50°C to obtain an oil phase;

(2)将水相与油相以及剩余制备原料在25-40℃下混合均质,得到所述强化肌肤屏障修复的乳液。(2) Mix and homogenize the water phase, the oil phase and the remaining preparation raw materials at 25-40°C to obtain the emulsion that strengthens skin barrier repair.

本发明所涉及的强化肌肤屏障修复的乳液的制备工艺简单易操作,非常适用于工业化生产。The preparation process of the emulsion for strengthening skin barrier repair involved in the present invention is simple and easy to operate, and is very suitable for industrial production.

所述25-40℃中的具体点值可以选择为25℃、30℃、35℃、40℃等;所述35-50℃中的具体点值可以选择为35℃、40℃、45℃、50℃等;上述各项数值范围内的其他具体点值均可选择,在此便不再一一赘述。The specific point values in 25-40°C can be selected as 25°C, 30°C, 35°C, 40°C, etc.; the specific point values in 35-50°C can be selected as 35°C, 40°C, 45°C, 50℃, etc.; other specific point values within the above numerical range can be selected, so I will not go into details here.

与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:

本发明创造性地将重组胶原蛋白、芋螺肽、裂褶菌多糖和依克多因四种组分进行联用,四者从不同维度全方位地改善皮肤的屏障受损问题同时强化肌肤屏障,四种组分相辅相成,存在潜在的相互促进效果,在上述功效上具有协同增效作用,能够高效改善由肌肤屏障受损引起的皮肤综合问题。The invention creatively combines four components: recombinant collagen, conotide, schizophyllan and ectoin. The four components comprehensively improve the problem of skin barrier damage from different dimensions while strengthening the skin barrier. The four components complement each other and have potential mutual promotion effects. They have a synergistic effect on the above-mentioned effects and can effectively improve comprehensive skin problems caused by damaged skin barriers.

具体实施方式Detailed ways

为更进一步阐述本发明所采取的技术手段及其效果,以下结合本发明的优选实施例来进一步说明本发明的技术方案,但本发明并非局限在实施例范围内。In order to further explain the technical means adopted by the present invention and its effects, the technical solutions of the present invention will be further described below with reference to preferred embodiments of the present invention, but the present invention is not limited to the scope of the embodiments.

下述内容中涉及的组合物产品中各组分的质量份数均以市售原料中实际有效成分含量来计算。The mass parts of each component in the composition product mentioned in the following content are calculated based on the actual active ingredient content in commercially available raw materials.

下述内容中涉及的金缕梅提取物来源于兰州沃特莱斯生物科技有限公司的产品;灯盏花提取物来源于兰州沃特莱斯生物科技有限公司的产品;裂褶菌多糖来源于兰州沃特莱斯生物科技有限公司的产品。其他原料均为本领域常用原料,均通过市售途径购买获得。The witch hazel extract involved in the following content comes from the products of Lanzhou Waterless Biotechnology Co., Ltd.; the Erigeron extract comes from the products of Lanzhou Waterless Biotechnology Co., Ltd.; the Schizophyllum polysaccharide comes from Lanzhou Products of Waterless Biotech Co., Ltd. Other raw materials are all commonly used raw materials in this field and are purchased through commercial channels.

下述内容中涉及的重组胶原蛋白使用的是制备例制得的产品,制备例中的pET-28a(+)载体购自麦克林;BL21(DE3)化学感受态细胞为购自默克货号为CMC0014-4X40UL的商品。The recombinant collagen involved in the following content is the product prepared in the preparation example. The pET-28a(+) vector in the preparation example was purchased from McLean; the BL21 (DE3) chemically competent cells were purchased from Merck. The product number is Product of CMC0014-4X40UL.

制备例Preparation example

本制备例提供一种重组胶原蛋白冻干粉,其制备方法参照ZL202310123476.3中制备例1公开的方法进行,具体如下:This preparation example provides a recombinant collagen freeze-dried powder, and its preparation method is carried out with reference to the method disclosed in preparation example 1 in ZL202310123476.3, as follows:

(1)重组质粒构建:按照SEQ ID NO:1所示的核苷酸序列,选择表达载体大肠杆菌宿主适用的pET-28a(+)载体,送至测序公司进行合成,制得重组胶原蛋白表达载体pET-28a-1。(1) Recombinant plasmid construction: According to the nucleotide sequence shown in SEQ ID NO: 1, select the pET-28a(+) vector suitable for the expression vector E. coli host, and send it to a sequencing company for synthesis to obtain recombinant collagen expression Vector pET-28a-1.

(2)重组发酵菌株构建:将pET-28a-1表达载体使用化学转化法转至大肠杆菌(BL21(DE3))感受态细胞中,利用琼脂糖凝胶电泳筛选转化后平板菌落中的阳性克隆子,将筛选出的阳性克隆子转接至2mL LB培养基,37℃,200rpm培养12h,培养后的菌液使用体积分数为50%的甘油稀释1倍,分装到冻存管中,冻存在-80℃条件下,制得重组胶原蛋白发酵菌株。(2) Construction of recombinant fermentation strain: Use chemical transformation method to transfer the pET-28a-1 expression vector into Escherichia coli (BL21 (DE3)) competent cells, and use agarose gel electrophoresis to screen the positive clones in the transformed plate colonies. Transfer the selected positive clones to 2 mL LB medium, culture at 37°C, 200 rpm for 12 hours, dilute the cultured bacterial liquid 1 time with 50% glycerol, aliquot into cryovials, and freeze Under the condition of -80℃, a recombinant collagen fermentation strain was obtained.

(3)重组发酵菌株发酵培养:将10μL重组胶原蛋白发酵菌液涂布于固体LB平板,37℃培养箱培养12h后,挑选单克隆,接种于50mL含50μg/mL卡那霉素含量的LB液体培养基中,置于摇床中37℃,200rpm培养14h,然后以1:100的比例接种200mL含50μg/mL卡那霉素含量的LB液体培养基中,37℃培养至菌液OD=0.6后加入IPTG,使终浓度达到1mM,继续培养4h,随后4℃,4000rpm,离心15min收集菌体。(3) Fermentation culture of recombinant fermentation strain: Spread 10 μL of recombinant collagen fermentation strain on a solid LB plate, culture it in a 37°C incubator for 12 hours, select a single clone, and inoculate it into 50 mL of LB containing 50 μg/mL kanamycin. In the liquid culture medium, place it in a shaker at 37°C and culture at 200 rpm for 14 hours, then inoculate 200 mL of LB liquid culture medium containing 50 μg/mL kanamycin at a ratio of 1:100, and culture at 37°C until the bacterial solution OD= After 0.6, add IPTG to reach a final concentration of 1mM, continue culturing for 4 hours, and then centrifuge at 4°C, 4000rpm for 15 minutes to collect the cells.

(4)重组胶原蛋白纯化:将菌体超声破碎后离心,沉淀使用TritonX-100洗涤液洗涤,再次离心去除上清,沉淀加入6M盐酸胍,并调节pH到8,充分溶解沉淀后将溶解液过镍亲和层析树脂,使用20mM、50mM、100mM、200mM、500mM浓度梯度咪唑溶液依次洗脱,洗脱液使用蛋白浓缩柱浓缩后,收集浓缩液透析过夜(透析袋,RC膜,14KD,扁平宽度44mm(生工F600112)),随后使用BCA试剂盒检测蛋白浓度,并按每5mg蛋白加入体积浓度5%的甘露醇水溶液0.5mL的比例与甘露醇水溶液混匀,随后使用冻干机在-40℃预冻10min,最后-35℃冻干,得到重组胶原蛋白冻干粉。(4) Purification of recombinant collagen: Ultrasonically disrupt the cells and centrifuge, wash the precipitate with TritonX-100 washing solution, centrifuge again to remove the supernatant, add 6M guanidine hydrochloride to the precipitate, and adjust the pH to 8. After fully dissolving the precipitate, add the solution Pass through nickel affinity chromatography resin, and use 20mM, 50mM, 100mM, 200mM, 500mM concentration gradient imidazole solution to elute in sequence. After the eluent is concentrated using a protein concentration column, the concentrated solution is collected and dialyzed overnight (dialysis bag, RC membrane, 14KD, Flat width 44mm (Sangon F600112)), then use the BCA kit to detect the protein concentration, and add 0.5mL of mannitol aqueous solution with a volume concentration of 5% per 5mg of protein and mix it with the mannitol aqueous solution, and then use a freeze dryer to Pre-freeze at -40°C for 10 minutes, and finally freeze-dry at -35°C to obtain recombinant collagen freeze-dried powder.

实施例1Example 1

本实施例提供一种肌肤屏障修复组合物,其以质量份数计由以下组分组成:重组胶原蛋白0.1份、芋螺肽0.5份、裂褶菌多糖0.3份和依克多因0.2份。各组分按质量配比物理混合均匀即可。This embodiment provides a skin barrier repair composition, which is composed of the following components in terms of parts by mass: 0.1 part of recombinant collagen, 0.5 part of conopeptide, 0.3 part of Schizophyllan, and 0.2 part of ectoin. All components can be physically mixed evenly according to mass ratio.

实施例2Example 2

本实施例提供一种肌肤屏障修复组合物,其以质量份数计由以下组分组成:重组胶原蛋白0.05份、芋螺肽1份、裂褶菌多糖0.1份和依克多因0.5份。各组分按质量配比物理混合均匀即可。This embodiment provides a skin barrier repair composition, which is composed of the following components in terms of parts by mass: 0.05 parts of recombinant collagen, 1 part of conopeptide, 0.1 part of Schizophyllan, and 0.5 part of ectoin. All components can be physically mixed evenly according to mass ratio.

实施例3Example 3

本实施例提供一种肌肤屏障修复组合物,其以质量份数计由以下组分组成:重组胶原蛋白0.1份、芋螺肽0.2份、裂褶菌多糖0.5份和依克多因0.2份。各组分按质量配比物理混合均匀即可。This embodiment provides a skin barrier repair composition, which is composed of the following components in terms of parts by mass: 0.1 part of recombinant collagen, 0.2 part of conopeptide, 0.5 part of Schizophyllan, and 0.2 part of ectoin. All components can be physically mixed evenly according to mass ratio.

对比例1Comparative example 1

本对比例提供一种组合物,其与实施例1的区别仅在于不含有重组胶原蛋白,将其减少的质量按比例分配至芋螺肽、裂褶菌多糖和依克多因的质量上,其他组分及含量保持不变。各组分按质量配比物理混合均匀即可。This comparative example provides a composition, which differs from Example 1 only in that it does not contain recombinant collagen, and its reduced mass is proportionally distributed to the mass of conopeptide, schizophyllan and ectoin, Other components and contents remain unchanged. All components can be physically mixed evenly according to mass ratio.

对比例2Comparative example 2

本对比例提供一种组合物,其与实施例1的区别仅在于不含有芋螺肽,将其减少的质量按比例分配至重组胶原蛋白、裂褶菌多糖和依克多因的质量上,其他组分及含量保持不变。各组分按质量配比物理混合均匀即可。This comparative example provides a composition, which differs from Example 1 only in that it does not contain conopeptide, and its reduced mass is proportionally distributed to the mass of recombinant collagen, Schizophyllan and ectoin, Other components and contents remain unchanged. All components can be physically mixed evenly according to mass ratio.

对比例3Comparative example 3

本对比例提供一种组合物,其与实施例1的区别仅在于不含有裂褶菌多糖,将其减少的质量按比例分配至芋螺肽、重组胶原蛋白和依克多因的质量上,其他组分及含量保持不变。各组分按质量配比物理混合均匀即可。This comparative example provides a composition, which differs from Example 1 only in that it does not contain Schizophyllan, and its reduced mass is proportionally distributed to the mass of conopeptide, recombinant collagen and ectoin, Other components and contents remain unchanged. All components can be physically mixed evenly according to mass ratio.

对比例4Comparative example 4

本对比例提供一种组合物,其与实施例1的区别仅在于不含有依克多因,将其减少的质量按比例分配至芋螺肽、裂褶菌多糖和重组胶原蛋白的质量上,其他组分及含量保持不变。各组分按质量配比物理混合均匀即可。This comparative example provides a composition, which differs from Example 1 only in that it does not contain ectoine, and its reduced mass is proportionally distributed to the mass of conopeptide, Schizophyllan and recombinant collagen, Other components and contents remain unchanged. All components can be physically mixed evenly according to mass ratio.

应用例1Application example 1

本应用例提供一种强化肌肤屏障修复的乳液,其配方包括如下成分:This application example provides an emulsion that strengthens skin barrier repair. Its formula includes the following ingredients:

其制备方法为:Its preparation method is:

(1)将水与肌肤屏障修复组合物在30℃下混合均质,得到水相;将油相与乳化剂在40℃下混合均质,得到油相;(1) Mix and homogenize water and the skin barrier repair composition at 30°C to obtain a water phase; mix and homogenize the oil phase and emulsifier at 40°C to obtain an oil phase;

(2)将水相与油相以及剩余制备原料在40℃下混合均质,得到所述强化肌肤屏障修复的乳液。(2) Mix and homogenize the water phase, the oil phase and the remaining preparation raw materials at 40°C to obtain the emulsion that strengthens skin barrier repair.

应用例2-3Application Example 2-3

本应用例提供两种强化肌肤屏障修复的乳液,其配方与应用例1的区别仅在于将实施例1的肌肤屏障修复组合物替换为等量的实施例2-3制得的肌肤屏障修复组合物,其他组分及含量保持不变。其制备方法为参照应用例1。This application example provides two emulsions that strengthen skin barrier repair. The only difference between their formulas and Application Example 1 is that the skin barrier repair composition of Example 1 is replaced with an equal amount of the skin barrier repair composition prepared in Examples 2-3. substance, other components and contents remain unchanged. The preparation method is as shown in Application Example 1.

应用例4Application example 4

本应用例提供一种强化肌肤屏障修复的乳液,其配方与应用例1的区别仅在于缺少白池花籽油,将其减少的质量按比例分配至甜扁桃油和葡萄籽油的质量上,其他组分及含量保持不变。其制备方法为参照应用例1。This application example provides an emulsion that strengthens skin barrier repair. The only difference between its formula and application example 1 is the lack of white pond flower seed oil. The reduced mass is allocated to the mass of sweet almond oil and grape seed oil in proportion. The other The ingredients and content remain unchanged. The preparation method is as shown in Application Example 1.

应用例5Application example 5

本应用例提供一种强化肌肤屏障修复的乳液,其配方与应用例1的区别仅在于缺少甜扁桃油,将其减少的质量按比例分配至白池花籽油和葡萄籽油的质量上,其他组分及含量保持不变。其制备方法为参照应用例1。This application example provides an emulsion that strengthens skin barrier repair. The only difference between its formula and application example 1 is the lack of sweet almond oil. The reduced mass is allocated to the mass of white pond flower seed oil and grape seed oil in proportion. The other The ingredients and content remain unchanged. The preparation method is as shown in Application Example 1.

应用例6Application example 6

本应用例提供一种强化肌肤屏障修复的乳液,其配方与应用例1的区别仅在于缺少葡萄籽油,将其减少的质量按比例分配至白池花籽油和甜扁桃油的质量上,其他组分及含量保持不变。其制备方法为参照应用例1。This application example provides an emulsion that strengthens skin barrier repair. The only difference between its formula and application example 1 is the lack of grape seed oil. The reduced mass is allocated to the mass of white pond flower seed oil and sweet almond oil in proportion. The other The ingredients and content remain unchanged. The preparation method is as shown in Application Example 1.

对比应用例1-4Comparative application examples 1-4

对比应用例1-4提供四种强化肌肤屏障修复的乳液,其配方与应用例1的区别仅在于将实施例1的肌肤屏障修复组合物替换为等量的对比例1-4制得的肌肤屏障修复组合物,其他组分及含量保持不变。其制备方法为参照应用例1。Comparative Application Examples 1-4 provide four emulsions that strengthen skin barrier repair. The only difference between their formulas and Application Example 1 is that the skin barrier repair composition of Example 1 is replaced with an equal amount of skin prepared by Comparative Examples 1-4. Barrier repair composition, other components and contents remain unchanged. The preparation method is as shown in Application Example 1.

对比应用例5Comparative application example 5

对比应用例5提供一种乳液,其配方与应用例1的区别仅在于缺少肌肤屏障修复组合物,其减少的质量由水补足,其他组分及含量保持不变。Comparative Application Example 5 provides an emulsion. The only difference between its formula and Application Example 1 is that it lacks the skin barrier repair composition. Its reduced mass is made up by water, and other components and contents remain unchanged.

应用例7Application example 7

本应用例提供一种强化肌肤屏障修复的乳液,其配方包括如下成分:This application example provides an emulsion that strengthens skin barrier repair. Its formula includes the following ingredients:

其制备方法为:Its preparation method is:

(1)将水与肌肤屏障修复组合物在30℃下混合均质,得到水相;将油相与乳化剂在40℃下混合均质,得到油相;(1) Mix and homogenize water and the skin barrier repair composition at 30°C to obtain a water phase; mix and homogenize the oil phase and emulsifier at 40°C to obtain an oil phase;

(2)将水相与油相与植物源调理剂以及剩余制备原料在40℃下混合均质,得到所述强化肌肤屏障修复的乳液。(2) Mix and homogenize the water phase and oil phase with the plant-derived conditioning agent and the remaining preparation raw materials at 40°C to obtain the emulsion that strengthens skin barrier repair.

应用例8Application example 8

本应用例提供一种强化肌肤屏障修复的乳液,其配方与应用例4的区别仅在于缺少金缕梅提取物,灯盏花提取物的质量百分含量为8%,其他组分及含量保持不变。This application example provides an emulsion that strengthens skin barrier repair. The only difference between its formula and application example 4 is the lack of witch hazel extract. The mass percentage of breviscapus extract is 8%, and other components and contents remain the same. Change.

应用例9Application example 9

本应用例提供一种强化肌肤屏障修复的乳液,其配方与应用例4的区别仅在于缺少灯盏花提取物,金缕梅提取物的质量百分含量为8%,其他组分及含量保持不变。This application example provides an emulsion that strengthens skin barrier repair. The only difference between its formula and application example 4 is the lack of breviscapus extract. The mass percentage of witch hazel extract is 8%. The other components and contents remain the same. Change.

测试例1Test example 1

安全性评价:Safety evaluation:

取应用例1-9和对比应用例1-5制得的产品置于斑试器中,将加有受试物的斑试器贴到受试人员(20名)前臂屈侧,用手掌轻压使之均匀地贴敷于皮肤上,持续24小时;分别于去除受试物斑试器后30min、24h、48h后按下表1观察皮肤刺激性和致敏性,并记录观察结果。Take the products prepared in Application Examples 1-9 and Comparative Application Examples 1-5 and place them in a patch tester. Place the patch tester containing the test substance on the flexor side of the forearm of the subject (20 people), and gently use the palm of your hand to Press to apply it evenly on the skin for 24 hours; observe skin irritation and sensitization according to Table 1 30 minutes, 24 hours, and 48 hours after removing the test substance spot tester, and record the observation results.

表1Table 1

结果显示,应用例1-9和对比应用例1-5制得的产品的评分等级均为0,即说明本发明所涉及的肌肤屏障修复组合物及其制得的乳液对皮肤安全无刺激。The results show that the scores of the products prepared in Application Examples 1-9 and Comparative Application Examples 1-5 are both 0, which means that the skin barrier repair composition involved in the present invention and the emulsion prepared therefrom are safe and non-irritating to the skin.

测试例2Test example 2

保湿效果评价:Moisturizing effect evaluation:

仪器为德国Courage+Khazaka electronic型号:Derma UnitSSC,测试温度25℃,湿度60%。选取150名皮肤健康的18-40岁的志愿者,男女各半,随机分成15组,每组5名男性、5名女性,分别使用应用例1-9和对比应用例1-5提供的产品,空白组不使用任何产品。在使用前以及使用5h后分别测试各位受试者的皮肤水分含水量(以使用前为100%计),每个数据测试三次,取平均值后,计算每组平均值,保留小数点后一位。结果如表2所示。The instrument is a German Courage+Khazaka electronic model: Derma UnitSSC. The test temperature is 25°C and the humidity is 60%. Select 150 volunteers aged 18-40 with healthy skin, half of them male and female, and randomly divide them into 15 groups, with 5 males and 5 females in each group, and use the products provided in Application Examples 1-9 and Comparative Application Examples 1-5 respectively. , the blank group does not use any products. Test the skin moisture content of each subject before use and after 5 hours of use (calculated as 100% before use). Each data is tested three times. After taking the average, calculate the average value of each group, retaining one decimal place. . The results are shown in Table 2.

表2Table 2

由表2数据可知,本发明所涉及的组合物及其制得的化妆品能够修复肌肤屏障,防止水分蒸发,帮助强化和恢复肌肤保湿状态,且重组胶原蛋白、芋螺肽、裂褶菌多糖和依克多因在上述功效上具有显著的协同增效作用,同时灯盏花提取物和金缕梅提取物的加入能够进一步提升产品的上述功效。It can be seen from the data in Table 2 that the composition involved in the present invention and the cosmetics prepared therefrom can repair the skin barrier, prevent water evaporation, help strengthen and restore the skin's moisturizing state, and recombinant collagen, conotide, Schizophyllan and Ecdoine has a significant synergistic effect on the above-mentioned effects, and the addition of Erigeron extract and witch hazel extract can further enhance the above-mentioned effects of the product.

测试例3Test example 3

抗过敏性能评价:Anti-allergic performance evaluation:

采用透明质酸酶体外抑制实验Elson-Morgan法进行。试样溶液组为取0.1mL0.25mmol/L CaCl2溶液和0.5mL透明质酸酶液37℃保温20min;分别加入0.5mL实施例1-3和对比例1-4产品的10%的稀释水溶液,继续37℃保温孵育20min;加入0.5mL透明质酸钠液37℃保温30min,常温放置5min;加入0.1mL0.4mol/L NaOH溶液和0.5mL乙酰丙酮溶液,置于沸水浴中加热15min后立即用冰水进行冷却5min;加入埃尔利希试剂1.0mL并用3.0mL无水乙醇进行稀释,放置20min显色,用分光光度计测定其吸光度值。计算公式:透明质酸酶抑制率(%)=[((A-B)-(C-D))/A-B]×100%,式中:A代表(透明质酸酶+去离子水+透明质酸钠)对照溶液的OD值,B代表(醋酸缓冲液+去离子水+醋酸缓冲液)对照空白溶液的OD值,C代表(透明质酸酶+样品+透明质酸钠)试样溶液的OD值,D代表(醋酸缓冲液+样品+醋酸缓冲液)试样空白溶液的OD值。The hyaluronidase in vitro inhibition test was performed using the Elson-Morgan method. The sample solution group is to take 0.1 mL of 0.25 mmol/L CaCl 2 solution and 0.5 mL of hyaluronidase solution and incubate them at 37°C for 20 min; add 0.5 mL of 10% diluted aqueous solution of the products of Examples 1-3 and Comparative Examples 1-4 respectively. , continue to incubate at 37℃ for 20min; add 0.5mL sodium hyaluronate solution and incubate at 37℃ for 30min, and leave it at room temperature for 5min; add 0.1mL0.4mol/L NaOH solution and 0.5mL acetylacetone solution, place it in a boiling water bath and heat for 15min immediately. Cool with ice water for 5 minutes; add 1.0 mL of Ehrlich's reagent and dilute it with 3.0 mL of absolute ethanol, leave it for 20 minutes to develop color, and measure the absorbance value with a spectrophotometer. Calculation formula: Hyaluronidase inhibition rate (%) = [((AB)-(CD))/AB]×100%, where A represents (hyaluronidase + deionized water + sodium hyaluronate) The OD value of the control solution, B represents the OD value of the (acetate buffer + deionized water + acetate buffer) control blank solution, C represents the OD value of the (hyaluronidase + sample + sodium hyaluronate) sample solution, D represents the OD value of the sample blank solution (acetate buffer + sample + acetate buffer).

每组样品平行测试三次,取平均值后,计算每组平均值,保留小数点后一位。结果如表3所示。Each group of samples was tested in parallel three times. After taking the average, calculate the average value of each group and keep it to one decimal place. The results are shown in Table 3.

表3table 3

组别Group 透明质酸酶抑制(%)Hyaluronidase inhibition (%) 实施例1Example 1 68.468.4 实施例2Example 2 66.766.7 实施例3Example 3 63.963.9 对比例1Comparative example 1 66.866.8 对比例2Comparative example 2 68.068.0 对比例3Comparative example 3 57.357.3 对比例4Comparative example 4 51.251.2

由表3数据可知,本发明所涉及的组合物具有优异的抑制透明质酸酶的功效,能够安抚肌肤的炎症反应和其他不适症状,维持肌肤的稳定和健康,且重组胶原蛋白、芋螺肽、裂褶菌多糖和依克多因在上述功效上具有显著的协同增效作用。It can be seen from the data in Table 3 that the composition involved in the present invention has excellent hyaluronidase inhibition effect, can soothe the skin's inflammatory response and other uncomfortable symptoms, maintain the stability and health of the skin, and recombinant collagen and conotase peptides , Schizophyllan and Ectoin have significant synergistic effects on the above-mentioned effects.

测试例4Test example 4

抗衰效果评价:Anti-aging effect evaluation:

仪器为德国Courage+Khazaka皮肤弹性测试仪MPA-580,测试温度25℃,湿度60%。选取150名皮肤健康的18-40岁的志愿者,男女各半,随机分成15组,每组5名男性、5名女性,受试者双手前臂内侧做好测量区域标记,实验区域至少3cm×3cm,每个测试区域之间间隔至少1cm。分别使用应用例1-9和对比应用例1-5提供的产品,对照组不使用任何产品。将14组受试样品按2ml/cm2的用量进行单次涂布(空白组为纯水)。使用乳胶手套将试样均匀涂布于试验区,轻轻拍打直至吸收。每天使用一次,坚持使用两周后,测定结果。将探头垂直轻触待测区域开始测试,直至测试循环结束移开探头。每个待测区域取三点进行测定,取平均值后,计算每组平均值。结果如表4所示。The instrument is the German Courage+Khazaka skin elasticity tester MPA-580, with a test temperature of 25°C and a humidity of 60%. 150 volunteers aged 18-40 with healthy skin were selected, half of them male and female, and randomly divided into 15 groups, with 5 males and 5 females in each group. The measurement area was marked on the inside of the forearm of both hands of the subjects, and the experimental area was at least 3cm× 3cm, with at least 1cm between each test area. The products provided in Application Examples 1-9 and Comparative Application Examples 1-5 were used respectively, and the control group did not use any products. 14 groups of test samples were coated in a single time at a dosage of 2ml/ cm2 (the blank group was pure water). Use latex gloves to apply the sample evenly to the test area and pat gently until absorbed. Use once a day for two weeks and measure the results. Touch the probe vertically to the area to be measured to start the test, and remove the probe until the test cycle is completed. Take three points for each area to be measured. After taking the average, calculate the average value of each group. The results are shown in Table 4.

表4Table 4

由表4数据可知,本发明所涉及的组合物及其制得的化妆品能够修复肌肤屏障,防止水分蒸发,帮助强化和恢复肌肤保湿状态,且重组胶原蛋白、芋螺肽、裂褶菌多糖和依克多因在上述功效上具有显著的协同增效作用,同时灯盏花提取物和金缕梅提取物的加入能够进一步提升产品的上述功效。It can be seen from the data in Table 4 that the composition involved in the present invention and the cosmetics prepared therefrom can repair the skin barrier, prevent water evaporation, help strengthen and restore the skin's moisturizing state, and recombinant collagen, conotide, Schizophyllan and Ecdoine has a significant synergistic effect on the above-mentioned effects, and the addition of Erigeron extract and witch hazel extract can further enhance the above-mentioned effects of the product.

申请人声明,本发明通过上述实施例来说明本发明的技术方案,但本发明并不局限于上述实施例,即不意味着本发明必须依赖上述实施例才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明产品各原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。The applicant declares that the present invention illustrates the technical solution of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvements to the present invention, equivalent replacement of raw materials of the product of the present invention, addition of auxiliary ingredients, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

以上详细描述了本发明的优选实施方式,但是,本发明并不限于上述实施方式中的具体细节,在本发明的技术构思范围内,可以对本发明的技术方案进行多种简单变型,这些简单变型均属于本发明的保护范围。The preferred embodiments of the present invention have been described in detail above. However, the present invention is not limited to the specific details of the above embodiments. Within the scope of the technical concept of the present invention, a variety of simple modifications can be made to the technical solutions of the present invention. These simple modifications All belong to the protection scope of the present invention.

另外需要说明的是,在上述具体实施方式中所描述的各个具体技术特征,在不矛盾的情况下,可以通过任何合适的方式进行组合,为了避免不必要的重复,本发明对各种可能的组合方式不再另行说明。In addition, it should be noted that each of the specific technical features described in the above-mentioned specific embodiments can be combined in any suitable manner without conflict. In order to avoid unnecessary repetition, the present invention combines various possible combinations. The combination method will not be further explained.

Claims (10)

1. A skin barrier repair composition comprising recombinant collagen, wherein the skin barrier repair composition comprises recombinant collagen, conopeptides, schizophyllan and ectofactor.
2. The skin barrier repair composition containing recombinant collagen according to claim 1, wherein the skin barrier repair composition comprises, in parts by mass, 0.01-2 parts of recombinant collagen, 0.1-3 parts of conopeptide, 0.1-0.5 part of schizophyllan and 0.1-1 part of ectoin.
3. The skin barrier repair composition containing recombinant collagen according to claim 1 or 2, wherein the nucleotide sequence encoding the recombinant collagen is the sequence shown in SEQ ID No. 1.
4. Use of the skin barrier repair composition containing recombinant collagen according to any one of claims 1 to 3 in the preparation of a cosmetic.
5. The use according to claim 4, wherein the skin barrier repair composition comprising recombinant collagen is present in the cosmetic in an amount of 0.1 to 15% by mass.
6. An emulsion for strengthening skin barrier repair is characterized by comprising the following preparation raw materials in percentage by mass: the skin barrier repair composition containing recombinant collagen according to any one of claims 1 to 3, 0.1 to 15%, an oil phase 1 to 20%, an emulsifier 1 to 10% and water 50 to 90%.
7. The skin barrier repair enhancing emulsion of claim 6, wherein the oil phase comprises any one or a combination of at least two of glycerol caprylate, squalane, olive oil, white pool seed oil, jojoba oil, shea butter, sweet almond oil, grape seed oil, caprylic/capric triglyceride, hydrogenated cocoglyceride, phytosterol isostearate, isononyl isononanoate, arachidyl alcohol, vitamin a, vitamin E, or vitamin F; preferably, a combination of white pool flower seed oil, sweet almond oil, grape seed oil and vitamin E;
preferably, the emulsifier comprises any one or a combination of at least two of glycerol stearate, cetostearyl alcohol, sodium stearoyl lactylate, glycerol stearate citrate, cholesterol, cetostearyl alcohol oleyl oleate, sorbitan stearate, polyglycerol-10 oleate or polysorbate-60.
8. The skin barrier repair enhancing emulsion according to claim 6 or 7, wherein the emulsion is prepared from the following raw materials in mass percent: 1-15% of plant source conditioning agent, 0.1-2% of pH regulator, 0.01-0.5% of chelating agent, 0.05-0.5% of antioxidant and 0.1-0.5% of aromatic agent or the combination of at least two.
9. The emulsion for enhancing skin barrier repair of claim 8, wherein the plant-derived conditioning agent comprises witch hazel extract and/or erigeron breviscapus extract.
10. A method of preparing an emulsion for enhancing skin barrier repair according to any one of claims 6 to 9, wherein the method of preparing comprises the steps of:
(1) Mixing water and skin barrier repair composition at 25-40deg.C, homogenizing to obtain water phase; mixing the oil phase with emulsifier at 35-50deg.C, and homogenizing to obtain oil phase;
(2) Mixing and homogenizing the water phase, the oil phase and the rest preparation raw materials at 25-40 ℃ to obtain the emulsion for reinforcing skin barrier repair.
CN202311625054.2A 2023-11-29 2023-11-29 A skin barrier repair composition containing recombinant collagen and its application Pending CN117598926A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311625054.2A CN117598926A (en) 2023-11-29 2023-11-29 A skin barrier repair composition containing recombinant collagen and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311625054.2A CN117598926A (en) 2023-11-29 2023-11-29 A skin barrier repair composition containing recombinant collagen and its application

Publications (1)

Publication Number Publication Date
CN117598926A true CN117598926A (en) 2024-02-27

Family

ID=89951212

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311625054.2A Pending CN117598926A (en) 2023-11-29 2023-11-29 A skin barrier repair composition containing recombinant collagen and its application

Country Status (1)

Country Link
CN (1) CN117598926A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117860641A (en) * 2024-03-12 2024-04-12 山东赫柏芳香生物科技有限公司 Production process of moisturizing skin-care emulsion cosmetics
CN118902888A (en) * 2024-09-23 2024-11-08 广东丸美生物技术股份有限公司 Cosmetic for repairing skin injury containing schizophyllan, preparation method and composition thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111407719A (en) * 2020-04-02 2020-07-14 广州一一生物技术有限公司 Skin barrier repair compound, face cream and preparation method thereof
CN111991309A (en) * 2020-08-20 2020-11-27 广州优理氏生物科技有限公司 Composition with repairing and moisturizing effects and preparation method and application thereof
CN112043619A (en) * 2020-08-20 2020-12-08 广州优理氏生物科技有限公司 Peptide composition with repairing effect and preparation method and application thereof
JP2022095528A (en) * 2020-12-16 2022-06-28 広東丸美生物技術股▲フン▼有限公司 Skin micro-ecosystem improvement composition, and preparation method and use thereof
CN116003577A (en) * 2023-02-14 2023-04-25 广东丸美生物技术股份有限公司 Recombinant collagen for skin soothing and repairing and application thereof
CN116763683A (en) * 2023-08-07 2023-09-19 上海颜遇医疗科技有限公司 Skin anti-aging composition and application thereof
CN117045559A (en) * 2023-09-11 2023-11-14 云南贝泰妮生物科技集团股份有限公司 Preparation method of erigeron breviscapus extract, product and application thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111407719A (en) * 2020-04-02 2020-07-14 广州一一生物技术有限公司 Skin barrier repair compound, face cream and preparation method thereof
CN111991309A (en) * 2020-08-20 2020-11-27 广州优理氏生物科技有限公司 Composition with repairing and moisturizing effects and preparation method and application thereof
CN112043619A (en) * 2020-08-20 2020-12-08 广州优理氏生物科技有限公司 Peptide composition with repairing effect and preparation method and application thereof
JP2022095528A (en) * 2020-12-16 2022-06-28 広東丸美生物技術股▲フン▼有限公司 Skin micro-ecosystem improvement composition, and preparation method and use thereof
CN116003577A (en) * 2023-02-14 2023-04-25 广东丸美生物技术股份有限公司 Recombinant collagen for skin soothing and repairing and application thereof
CN116763683A (en) * 2023-08-07 2023-09-19 上海颜遇医疗科技有限公司 Skin anti-aging composition and application thereof
CN117045559A (en) * 2023-09-11 2023-11-14 云南贝泰妮生物科技集团股份有限公司 Preparation method of erigeron breviscapus extract, product and application thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
东亚肌肤健康研究中心等: "《天然植物原料护肤功效汇编》", 31 December 2022, 东方出版中心, pages: 330 - 332 *
杨占国等: "《仁用扁桃栽培与加工利用技术》", 31 August 2010, 科学技术文献出版社, pages: 3 *
王慎明: "《芳香精油图鉴》", 30 April 2016, 山西科学技术出版社, pages: 168 *
苏文等: "《秋季养生计划》", 31 October 2006, 科学技术文献出版社, pages: 148 *
黄亚东等: "《基因工程技术与重组多肽的开发应用》", 31 May 2021, 华中科技大学出版社, pages: 105 - 106 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117860641A (en) * 2024-03-12 2024-04-12 山东赫柏芳香生物科技有限公司 Production process of moisturizing skin-care emulsion cosmetics
CN117860641B (en) * 2024-03-12 2024-05-17 山东赫柏芳香生物科技有限公司 Production process of moisturizing skin-care emulsion cosmetics
CN118902888A (en) * 2024-09-23 2024-11-08 广东丸美生物技术股份有限公司 Cosmetic for repairing skin injury containing schizophyllan, preparation method and composition thereof

Similar Documents

Publication Publication Date Title
CN117598926A (en) A skin barrier repair composition containing recombinant collagen and its application
CN105769698B (en) Preservative-free cosmetic composition and application thereof
JP7601957B2 (en) Recombinant collagen for skin soothing and repair and uses thereof
CN118304226B (en) Barrier repairing composition containing camellia chrysantha extract, and preparation method and application thereof
CN112402347A (en) A kind of acne-removing and repairing composition containing fibronectin and preparation method thereof
CN113018228B (en) Anti-aging composition, cream and preparation method thereof
CN118001197A (en) Composition of recombinant humanized collagen, preparation method and application thereof
CN109498543A (en) The composition of adjustable skin microecological balance and its application and comprising its milky lotion and milky lotion preparation method
CN116172928A (en) Composition suitable for sensitive muscles and having moisturizing, anti-wrinkle and tightening effects and application thereof
CN111991309A (en) Composition with repairing and moisturizing effects and preparation method and application thereof
CN109172422B (en) Hyaluronic acid mask liquid and preparation method thereof
JP3558349B2 (en) Whitening cosmetics
CN110215417B (en) Soft moisturizing lotion and preparation method thereof
CN116459171B (en) Composition with allergy-relieving and repairing effects, essence and preparation method thereof
CN116139060B (en) Composition with anti-inflammatory and anti-aging effects and preparation method and application thereof
CN117481997A (en) Acne-removing repair composition containing recombinant collagen and application thereof
CN110236986B (en) Moisturizing lotion with refreshing and moistening functions and preparation method thereof
CN108354878B (en) Composition with moisturizing effect and cosmetic containing composition
CN112494392A (en) Clean oil-in-water cosmetic composition and preparation method thereof
CN113766922A (en) Dextran sulfate for inflammatory skin diseases
CN108159247B (en) Protective composition containing peach blossom extract and application thereof
CN117442525B (en) Composition with moisturizing effect and application thereof
CN115778881B (en) Skin care composition capable of relieving, moisturizing and refreshing, preparation method and application
CN118319824B (en) Moisturizing and soothing essence and preparation method thereof
CN113143841B (en) Whitening and moisturizing gel mask containing calendula officinalis extract as well as preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination